poppk model of osimertinib
Indication: EGFR-mutated non-small cell lung cancer
Population PK and exposure-response simulator for osimertinib, a third-generation EGFR tyrosine kinase inhibitor used in EGFR-mutant NSCLC. Includes parent drug, AZ5104 metabolite, and exposure links to QTc and selected adverse events.
Drug Overview
Clinical Context
- Molecular Target
- EGFR mutant kinase
- Drug Class
- EGFR Tyrosine Kinase Inhibitor
- Therapeutic Area
- Oncology / NSCLC
- Indication
- EGFR-mutated non-small cell lung cancer
- Route of Administration
- Oral
Model Information
- Model Type
- Population PK/Exposure-Response
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for poppk model of osimertinib allows you to explore concentration-time profiles under different dosing scenarios. The underlying Population PK/Exposure-Response model characterizes the pharmacokinetics of this egfr tyrosine kinase inhibitor following oral administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the poppk model of osimertinib PK simulator?
This is a free, interactive pharmacokinetic simulator for poppk model of osimertinib used in EGFR-mutated non-small cell lung cancer. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does poppk model of osimertinib belong to?
poppk model of osimertinib is classified as a EGFR Tyrosine Kinase Inhibitor that targets EGFR mutant kinase. It is used in the Oncology / NSCLC therapeutic area.
What route of administration does this model simulate?
This simulator models Oral administration of poppk model of osimertinib. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a Population PK/Exposure-Response model. This model characterizes the time-course of drug concentrations following dosing.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Ready to Simulate?
Launch the poppk model of osimertinib simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community